Latest filing published 07 Oct 2026 for Twist Bioscience Corp, €328k. Read the official filing
This profile gathers the share dealings of Emily M. Leproust across 2 companies, led by Twist Bioscience Corp and GeneDx Holdings Corp. Over a trading history stretching from 12 May 2021 to 5 October 2026, the count stands at 164 filings.
The open-market record consists of 96 sales worth €88.6M, with no purchase. No amount is published for 1 filing, which the totals therefore leave out. Other entries cover 42 share grants and 22 option exercises. So far in 2026, the count stands at no purchases and 52 sales.
Most recently, on 7 October 2026, the filings show an open-market sale worth €328k in Twist Bioscience Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 164 declarations